General inflammatory/immunity biomarkers, as C-reactive protein (CRP), interleukins, have been associated with the occurrence and prognosis of NAFLD, including the link to vascular events (15, 18–21). The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.